A recall of approximately 700,000 units of eye drop bottles has been initiated due to concerns over the lack of assurance regarding the sterility of their manufacturing process, potentially posing a health risk to consumers.
The U.S. Food and Drug Administration (FDA) has issued a warning on its official website regarding products withdrawn from the market by Sterling Pharmaceutical Services LLC, a company based in Dupo, Illinois, which distributed its products through the Walgreens retail chain.
The health authority initiated a product withdrawal on August 20 of this year, categorizing it as a Class II recall due to potential risks of temporary or serious adverse health effects for patients using the product.
Several eye medications have been recalled from the market due to safety concerns.
The US Food and Drug Administration has advised consumers to discontinue use of certain eye drops and discard them, or return them to the point of purchase for a refund. This precaution is necessary due to concerns over the potential for contamination and lack of sterility in some eye care products, which can lead to a range of adverse effects, including eye irritation, infection, and vision problems.
